Non-regulatory Press releases
THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER
Malmö, 29 November 2023 Download the press release as PDF here Pila Pharma AB (publ) ("Pila Pharma" or the "Company") hereby informs that the subscription period in Company's rights issue of shares that was initiated on 20 November 2023 has entered its second subscription week and and will run until Monday 4 December 2023. The last day of trading subscription…
PILA PHARMA WILL PRESENT AT “STORA AKTIEDAGARNA” IN STOCKHOLM TOMORROW, 27 NOVEMBER 2023 AT 8:00 CET
Malmö, 26 November 2023 Download the press release as PDF here On Monday 27 November 2023 at 8:00 CET, the CEO of Pila Pharma will present the company's business and ongoing rights issue at the event "Stora Aktiedagarna" in Stockholm. The presentation can be viewed onsite or via live stream. Adress: Birger Jarlsgatan 61 A, Stockholm Live stream: https://invitepeople.com/public/events/af87c9f59a/pages/aa3d4312cf No registration…
PILA PHARMA PUBLISHES INFORMATION MEMORANDUM
Malmö, 17 November 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE SUBJECT TO LEGAL RESTRICTIONS.…
Pila Pharma invites to After-Work investor meetings
Malmö, 7 November 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to an exciting evening of conversation when we host an after-work investor event near you! CEO & Founder Dorte X. Gram will elaborate on Pila Pharma and its innovative pill-treatment for obesity, diabetes and other related disorders. In the Q&A…
Pila Pharma ändrar språk för informationsgivning till engelska
Malmö, 22 augusti 2023 Läs pressmeddelandet som PDF här Styrelsen för Pila Pharma AB (publ) har beslutat att ändra kommunikationsspråk till engelska till följd av att bolaget har en internationell styrelse där endast 2 av 4 ledamöter har svensk bakgrund. Bolaget upplever även ett ökat intresse från internationella investerare. Övergången kommer att genomföras i samband med publicering av bolagets kvartals…